Moderna CEO Talks New Drugs

Moderna CEO Talks New Drugs

Up next

Lightspeed Venture Partners' Sebastian Duesterhoeft Talks Investing in Anthropic

As Anthropic goes public after a historic IPO, Sebastian Duesterhoeft, Partner at Lightspeed Venture Partners, talks Anthropic's first day of trading and how it feels to be investing in the company. He spoke to Bloomberg's Carol Massar, Tim Stenovec and Ed Ludlow.See omnystudio.c ...  Show more

Nasdaq President Nelson Griggs Talks Anthropic IPO

Nelson Griggs, president of Nasdaq, discusses how the Nasdaq has captured three of the biggest IPOs in history - SpaceX, SK Hynix and now Anthropic. He talks about the ANT listing and what to expect once shares start trading. He joins Ed Ludlow from the Nasdaq on “Bloomberg Tech. ...  Show more

Recommended Episodes

SEC to Demand More Transparency From China
Bloomberg Businessweek

Dr. Vino Palli, CEO of MiDoctor Urgent Care, discusses the Covid virus and vaccinations. Businessweek Technology Editor Joshua Brustein talks about his Businessweek Magazine story Afghanistan War Turns a U.S. Military Startup Into a Unicorn. Bloomberg News Financial Regulations R ...  Show more

Heal Chief Medical Officer on COVID-19 Vaccine Distribution
Bloomberg Businessweek

Dr. Renee Dua, Chief Medical Officer of Heal, provides a coronavirus and vaccine update. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Real Estate Reporter Patrick Clark talk about the story “Airbnb Salvaged Its IPO by Mastering the Pandemic Pivot.” Bloomberg News E ...  Show more

The State of EVs, Outlook for Crypto, Talent Strategies
Bloomberg Businessweek

On this edition of Bloomberg Businessweek, hosts Paul Sweeney and Matt Miller speak with Daniel Barel, CEO of REE Automotive, Chris Heller, co-founder of Cordillera Investment Partners, Nicola Hancock, Managing Director of the Americas at AMS, Vinh Vuong, CEO at Garrison Fathom a ...  Show more